|
US7355017B2
(en)
*
|
2001-07-20 |
2008-04-08 |
Absorber Ab |
Blood group antigen fusion polypeptides and methods of use thereof
|
|
AU2003233008B2
(en)
*
|
2002-04-22 |
2008-04-24 |
Recopharma Ab |
Fusion polypeptides and methods for inhibiting microbial adhesion
|
|
EP1517700B1
(en)
*
|
2002-04-22 |
2012-03-28 |
Recopharma AB |
Mucin fusion polypeptide vaccines, compositions and methods of use thereof
|
|
JP5183010B2
(ja)
|
2002-05-16 |
2013-04-17 |
グリコミメティクス， インコーポレイテッド |
セレクチンによって媒介される機能を阻害するための化合物および方法
|
|
CA2490703A1
(en)
*
|
2002-07-03 |
2004-01-15 |
Glycomimetics, Inc. |
Compositions and methods for diagnosis and therapy of medical conditions involving angiogenesis
|
|
US7638323B2
(en)
*
|
2002-08-09 |
2009-12-29 |
Recopharma Ab |
Fusion proteins and methods of producing same
|
|
US20050076759A1
(en)
*
|
2003-10-08 |
2005-04-14 |
Brian Westfall |
Linear saw with stab-cut bevel capability
|
|
US20040219158A1
(en)
*
|
2003-05-02 |
2004-11-04 |
Glycomimetics, Inc. |
Compositions and methods for diagnosis and therapy of medical conditions involving infection with pseudomonas bacteria
|
|
US7459523B2
(en)
*
|
2003-11-12 |
2008-12-02 |
Wisconsin Alumni Research Foundation |
Equine P-selectin glycoprotein ligand-1 and uses thereof
|
|
CA2546784A1
(en)
*
|
2003-11-19 |
2005-06-16 |
Glycomimetics, Inc. |
Glycomimetic antagonists for both e- and p-selectins
|
|
DE602004011272T2
(de)
*
|
2003-11-19 |
2008-12-24 |
Glycomimetics, Inc. |
Spezifischer antagonist sowohl für e- als auch p-selektine
|
|
EP1782838A4
(en)
*
|
2004-06-23 |
2007-08-01 |
Japan Science & Tech Agency |
INHIBITION OF INFILTRATION AND CELL-COOLING MEDIUM
|
|
US8201377B2
(en)
*
|
2004-11-05 |
2012-06-19 |
Faus Group, Inc. |
Flooring system having multiple alignment points
|
|
WO2006127906A1
(en)
*
|
2005-05-25 |
2006-11-30 |
Glycomimetics, Inc. |
Heterobifunctional compounds for selectin inhibition
|
|
DK1928892T3
(da)
*
|
2005-08-09 |
2012-01-30 |
Glycomimetics Inc |
Glycomimetiske inhibitorer af PA-IL-lectin PA-IIL-lectin eller begge lectiner fra pseudomonas
|
|
PL1934236T3
(pl)
*
|
2005-09-02 |
2013-04-30 |
Glycomimetics Inc |
Heterobifunkcjonalne inhibitory pan-selektyny
|
|
US20070113297A1
(en)
*
|
2005-09-13 |
2007-05-17 |
Yongguang Yang |
Methods and compositions for inhibition of immune responses
|
|
AU2007251256B2
(en)
*
|
2006-01-26 |
2013-03-07 |
Recopharma Ab |
Compositions and methods for inhibiting viral adhesion
|
|
US20070178447A1
(en)
*
|
2006-01-31 |
2007-08-02 |
Bethyl Laboratories, Inc. |
Method for decreasing interference in results of immunochemical methods
|
|
WO2007143052A1
(en)
*
|
2006-06-01 |
2007-12-13 |
Glycomimetics, Inc. |
Galactosides and thiodigalactosides as inhibitors of pa-il lectin from pseudomonas
|
|
CA2666103C
(en)
|
2006-10-12 |
2014-02-18 |
Glycomimetics, Inc. |
Glycomimetic replacements for hexoses and n-acetyl hexosamines
|
|
US7998486B2
(en)
*
|
2006-10-25 |
2011-08-16 |
Newlink Genetics Corporation |
Enhanced immunogenicity of tumor associated antigens by addition of alphaGal epitopes
|
|
WO2008100453A1
(en)
*
|
2007-02-09 |
2008-08-21 |
Glycomimetics, Inc. |
Methods of use of glycomimetics with replacements for hexoses and n-acetyl hexosamines
|
|
US8039442B2
(en)
*
|
2007-07-18 |
2011-10-18 |
Glycomimetics, Inc. |
Compounds and methods for treatment of sickle cell disease or complications associated therewith
|
|
US8895510B2
(en)
|
2008-04-08 |
2014-11-25 |
Glycomimetics, Inc. |
Pan-selectin inhibitor with enhanced pharmacokinetic activity
|
|
WO2009152245A1
(en)
*
|
2008-06-13 |
2009-12-17 |
Glycomimetics, Inc. |
Treatment of cancers of the blood using selected glycomimetic compounds
|
|
CA2760292A1
(en)
|
2009-05-01 |
2010-11-04 |
Glycomimetics, Inc. |
Heterobifunctional inhibitors of e-selectins and cxcr4 chemokine receptors
|
|
US9420770B2
(en)
|
2009-12-01 |
2016-08-23 |
Indiana University Research & Technology Corporation |
Methods of modulating thrombocytopenia and modified transgenic pigs
|
|
WO2012037034A1
(en)
|
2010-09-14 |
2012-03-22 |
Glycomimetics, Inc. |
E-selectin antagonists
|
|
WO2012085165A1
(en)
*
|
2010-12-21 |
2012-06-28 |
Recopharma Ab |
Tear substitutes
|
|
WO2013096926A1
(en)
|
2011-12-22 |
2013-06-27 |
Glycomimetics, Inc. |
E-selectin antagonist compounds, compositions, and methods of use
|
|
PT2928476T
(pt)
|
2012-12-07 |
2018-05-10 |
Glycomimetics Inc |
Compostos, composições e métodos que utilizam antagonistas de e-selectina para mobilização de células hematopoiéticas
|
|
WO2016089872A1
(en)
|
2014-12-03 |
2016-06-09 |
Glycomimetics, Inc. |
Heterobifunctional inhibitors of e-selectins and cxcr4 chemokine receptors
|
|
US11045485B2
(en)
|
2016-01-22 |
2021-06-29 |
Glycomimetics, Inc. |
Glycomimetic inhibitors of PA-IL and PA-IIL lectins
|
|
US11291678B2
(en)
|
2016-03-02 |
2022-04-05 |
Glycomimetics, Inc |
Methods for the treatment and/or prevention of cardiovascular disease by inhibition of E-selectin
|
|
JP2019524791A
(ja)
|
2016-08-08 |
2019-09-05 |
グリコミメティクス， インコーポレイテッド |
Ｅ−セレクチンの阻害剤もしくはｃｘｃｒ４の阻害剤との、またはｅ−セレクチンおよびｃｘｃｒ４両方のヘテロ二機能性阻害剤とのｔ細胞チェックポイント阻害剤の組み合わせ
|
|
US11072625B2
(en)
|
2016-10-07 |
2021-07-27 |
Glycomimetics, Inc. |
Highly potent multimeric e-selectin antagonists
|
|
CA3054605A1
(en)
|
2017-03-15 |
2018-09-20 |
Glycomimetics, Inc. |
Galactopyranosyl-cyclohexyl derivatives as e-selectin antagonists
|
|
US11712446B2
(en)
|
2017-11-30 |
2023-08-01 |
Glycomimetics, Inc. |
Methods of mobilizing marrow infiltrating lymphocytes and uses thereof
|
|
BR112020013198A2
(pt)
|
2017-12-29 |
2020-12-01 |
Glycomimetics, Inc. |
inibidores heterobifuncionais de e-selectina e galectina-3
|
|
KR20200128025A
(ko)
|
2018-03-05 |
2020-11-11 |
글리코미메틱스, 인크. |
급성 골수성 백혈병 및 관련 병태의 치료 방법
|
|
WO2019241386A1
(en)
*
|
2018-06-12 |
2019-12-19 |
Rush University Medical Center |
Methods for enhanced endothelialization of implanted material
|
|
WO2020139962A1
(en)
|
2018-12-27 |
2020-07-02 |
Glycomimetics, Inc. |
Heterobifunctional inhibitors of e-selectin and galectin-3
|